Quick Answer
Acetyl-L-Carnitine Fatigue Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: because of evidence of its use by athletes with the intention of enhancing performance The World Anti-Doping Agency (WADA) classified Meldonium as a prohibited substance effective January 1, 2016.
Key Takeaways
- 01because of evidence of its use by athletes with the intention of enhancing performance The World Anti-Doping Agency (WADA) classified Meldonium as a prohibited substance effective January 1, 2016. [Malm Christer (2026)]
- 02The decision to move Meldonium from the Monitoring program to the Prohibited list was made “…” (WADA 2016 Prohibited List, 16 September 2015), rather than robust scientific evidence demonstrating actual performance enhancement. [Malm Christer (2026)]
- 03To date, scientific consensus on Meldonium’s ergogenic effects in humans remains inconclusive, prompting a need for a critical evaluation of the existing evidence hierarchy. [Malm Christer (2026)]
- 041 2 β While Western countries commonly refer to substances like Meldonium as “metabolic modulators,” in Eastern countries, they are frequently classified as “antihypoxic agents” (). [Malm Christer (2026)]
The current Migaku evidence database contains 2 reusable source documents for Acetyl-L-Carnitine Fatigue Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- because of evidence of its use by athletes with the intention of enhancing performance The World Anti-Doping Agency (WADA) classified Meldonium as a prohibited substance effective January 1, 2016. [Malm Christer (2026); evidence level 4]
- The decision to move Meldonium from the Monitoring program to the Prohibited list was made “…” (WADA 2016 Prohibited List, 16 September 2015), rather than robust scientific evidence demonstrating actual performance enhancement. [Malm Christer (2026); evidence level 4]
- To date, scientific consensus on Meldonium’s ergogenic effects in humans remains inconclusive, prompting a need for a critical evaluation of the existing evidence hierarchy. [Malm Christer (2026); evidence level 4]
- 1 2 β While Western countries commonly refer to substances like Meldonium as “metabolic modulators,” in Eastern countries, they are frequently classified as “antihypoxic agents” (). [Malm Christer (2026); evidence level 4]
- 1 2 2 3 4 Fibromyalgia (FM) is a disorder of and is frequently associated with other symptoms such as fatigue, sleep disturbances, muscle stiffness, depression, and anxiety [,]. [do Lago Isabella Oliveira (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources